ICON PLC (ICLR): Price and Financial Metrics

ICON PLC (ICLR): $219.00

1.74 (+0.80%)

POWR Rating

Component Grades














  • ICLR scores best on the Growth dimension, with a Growth rank ahead of 91.55% of US stocks.
  • The strongest trend for ICLR is in Growth, which has been heading up over the past 179 days.
  • ICLR's current lowest rank is in the Quality metric (where it is better than 33.04% of US stocks).

ICLR Stock Summary

  • With a market capitalization of $18,339,717,900, ICON PLC has a greater market value than 89.22% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, ICON PLC is reporting a growth rate of 108.3%; that's higher than 86.18% of US stocks.
  • As for revenue growth, note that ICLR's revenue has grown 75.95% over the past 12 months; that beats the revenue growth of 88.62% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ICON PLC are FWONA, DRI, LBRDA, MOS, and CACC.
  • Visit ICLR's SEC page to see the company's official filings. To visit the company's web site, go to www.iconplc.com.

ICLR Valuation Summary

  • In comparison to the median Healthcare stock, ICLR's EV/EBIT ratio is 447.37% higher, now standing at 41.6.
  • ICLR's price/sales ratio has moved up 0.4 over the prior 243 months.

Below are key valuation metrics over time for ICLR.

Stock Date P/S P/B P/E EV/EBIT
ICLR 2022-11-01 2.1 2.0 76.3 41.6
ICLR 2022-10-31 2.1 2.0 76.8 41.8
ICLR 2022-10-28 2.1 2.0 77.4 42.1
ICLR 2022-10-27 2.1 1.9 74.5 40.8
ICLR 2022-10-26 2.1 2.0 76.8 41.8
ICLR 2022-10-25 2.1 2.0 76.4 41.6

ICLR Growth Metrics

    Its 3 year revenue growth rate is now at 146.16%.
  • The 5 year net cashflow from operations growth rate now stands at 77.72%.
  • The 4 year revenue growth rate now stands at 70.78%.
ICLR's revenue has moved up $4,782,591,000 over the prior 30 months.

The table below shows ICLR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 7,588.43 997.754 209.902
2022-06-30 7,588.43 997.754 209.902
2022-03-31 6,524.392 944.138 168.033
2022-03-31 6,524.392 944.138 168.033
2021-12-31 5,480.826 829.142 153.185
2021-09-30 4,355.934 734.746 177.951

ICLR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ICLR has a Quality Grade of B, ranking ahead of 84.72% of graded US stocks.
  • ICLR's asset turnover comes in at 0.882 -- ranking 150th of 561 Business Services stocks.
  • 500 - Internal server error

The table below shows ICLR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.882 0.292 0.489
2019-12-31 1.067 0.296 0.542
2018-12-31 1.153 0.300 0.447
2017-12-31 0.885 0.416 0.420
2016-12-31 0.940 0.423 0.403
2015-12-31 0.970 0.423 0.516

ICLR Price Target

For more insight on analysts targets of ICLR, see our ICLR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $205.14 Average Broker Recommendation 1.72 (Moderate Buy)

ICLR Stock Price Chart Interactive Chart >

Price chart for ICLR

ICLR Price/Volume Stats

Current price $219.00 52-week high $313.00
Prev. close $217.26 52-week low $171.43
Day low $215.76 Volume 173,600
Day high $219.95 Avg. volume 567,733
50-day MA $196.14 Dividend yield N/A
200-day MA $218.90 Market Cap 17.82B

ICON PLC (ICLR) Company Bio

ICON Public Limited Company provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company was founded in 1990 and is based in Dublin, Ireland.

ICLR Latest News Stream

Event/Time News Detail
Loading, please wait...

ICLR Latest Social Stream

Loading social stream, please wait...

View Full ICLR Social Stream

Latest ICLR News From Around the Web

Below are the latest news stories about ICON PLC that investors may wish to consider to help them evaluate ICLR as an investment opportunity.

ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference

DUBLIN, November 23, 2022--ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference

Yahoo | November 23, 2022

‘The next four weeks will be better’: Jim Cramer sees reasons to be more positive on stocks and gives these 2 names his stamp of approval

Unhappy with the state of the portfolio after miserable 2022 stock market action? You are probably far from alone. Most investors have struggled to make headway in this year’s ongoing bear market, which has provided only short periods of relief. That said, with the year’s end getting ever nearer, Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program, thinks the bears are showing signs of exhaustion and this spells good news for battered investors.

Marty Shtrubel on TipRanks | November 20, 2022

ICON upgraded to buy at BofA on core growth, deal synergies

BofA Securities has upgraded contract research organization ICON plc (ICON) to buy from neutral citing the integration of PRA Health Sciences and confidence in core growth.

Seeking Alpha | November 9, 2022

ICON Public Limited Company (ICLR) Q3 2022 Earnings Call Transcript

ICON Public Limited Company (NASDAQ:NASDAQ:ICLR) Q3 2022 Earnings Conference Call November 03, 2022 08:00 AM ET Company Participants Kate Haven - Vice President of Investor Relations…

Seeking Alpha | November 5, 2022

ICON Public Limited Company 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:ICLR)

The following slide deck was published by ICON Public Limited Company in conjunction with their 2022 Q3 earnings call.

Seeking Alpha | November 5, 2022

Read More 'ICLR' Stories Here

ICLR Price Returns

1-mo 14.19%
3-mo 2.60%
6-mo N/A
1-year -19.49%
3-year 33.90%
5-year 87.98%
YTD -29.29%
2021 58.84%
2020 13.21%
2019 33.29%
2018 15.21%
2017 49.14%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6371 seconds.